Delirium at the End of Life.

Agar, M; Bush, SH

Delirium at the End of Life.

Agar, M

Bush, SH

Permalink

Publisher:: W B SAUNDERS CO-ELSEVIER INC
Publication Type:: Journal Article
Citation:: The Medical clinics of North America, 2020, 104, (3), pp. 491-501
Issue Date:: 2020-05

Recently Added

	Filename	Description	Size
	CH0010_Agar_v5_MA edits.docx	Submitted version	173.36 kB	Unknown	View/Open
	MED 32312411 am combined .pdf	Accepted Manuscript Version	383.33 kB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Open Access

This item is new to OPUS and is not currently available.

Full metadata record

Field	Value	Language
dc.contributor.author	Agar, M https://orcid.org/0000-0002-6756-6119
dc.contributor.author	Bush, SH
dc.date.accessioned	2021-02-24T21:17:34Z
dc.date.available	2021-02-24T21:17:34Z
dc.date.issued	2020-05
dc.identifier.citation	The Medical clinics of North America, 2020, 104, (3), pp. 491-501
dc.identifier.issn	0025-7125
dc.identifier.issn	1557-9859
dc.identifier.uri	http://hdl.handle.net/10453/146420
dc.description.abstract	Delirium is a prevalent acute neurocognitive condition in patients with progressive life-limiting illness. Delirium remains underdetected; a systematic approach to screening is essential. Delirium at the end of life requires a comprehensive assessment. Consider the potential for reversibility, illness trajectory, patient preference, and goals of care before proceeding with investigations and interventions. Management should be interdisciplinary, and nonpharmacologic therapy is fundamental. For patients with refractory and severe agitation or perceptual disturbance, judicious use of medication may also be required. Carers and family should be seen as partners in care and be involved in shared decision making about care.
dc.format	Print-Electronic
dc.language	eng
dc.publisher	W B SAUNDERS CO-ELSEVIER INC
dc.relation.ispartof	The Medical clinics of North America
dc.relation.isbasedon	10.1016/j.mcna.2020.01.006
dc.rights	info:eu-repo/semantics/restrictedAccess
dc.subject	1103 Clinical Sciences
dc.subject.classification	General & Internal Medicine
dc.subject.mesh	Humans
dc.subject.mesh	Delirium
dc.subject.mesh	Perceptual Disorders
dc.subject.mesh	Antipsychotic Agents
dc.subject.mesh	Mass Screening
dc.subject.mesh	Palliative Care
dc.subject.mesh	Terminal Care
dc.subject.mesh	Prevalence
dc.subject.mesh	Patient Care Planning
dc.subject.mesh	Emergence Delirium
dc.subject.mesh	Antipsychotic Agents
dc.subject.mesh	Delirium
dc.subject.mesh	Emergence Delirium
dc.subject.mesh	Humans
dc.subject.mesh	Mass Screening
dc.subject.mesh	Palliative Care
dc.subject.mesh	Patient Care Planning
dc.subject.mesh	Perceptual Disorders
dc.subject.mesh	Prevalence
dc.subject.mesh	Terminal Care
dc.title	Delirium at the End of Life.
dc.type	Journal Article
utslib.citation.volume	104
utslib.location.activity	United States
utslib.for	1103 Clinical Sciences
pubs.organisational-group	/University of Technology Sydney/Faculty of Health
pubs.organisational-group	/University of Technology Sydney/Faculty of Health/IMPACCT
pubs.organisational-group	/University of Technology Sydney
utslib.copyright.status	recently_added	*
dc.date.updated	2021-02-24T21:17:32Z
pubs.issue	3
pubs.publication-status	Published
pubs.volume	104
utslib.citation.issue	3

Abstract:

Delirium is a prevalent acute neurocognitive condition in patients with progressive life-limiting illness. Delirium remains underdetected; a systematic approach to screening is essential. Delirium at the end of life requires a comprehensive assessment. Consider the potential for reversibility, illness trajectory, patient preference, and goals of care before proceeding with investigations and interventions. Management should be interdisciplinary, and nonpharmacologic therapy is fundamental. For patients with refractory and severe agitation or perceptual disturbance, judicious use of medication may also be required. Carers and family should be seen as partners in care and be involved in shared decision making about care.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/146420